Thus, the high incidence (50 % of MM biopsies) of TrkA amplification we reported in this study (Fig. 2a) might suggest that this is a prominent mechanism in primary MM to increase TrkA gene dosage during the initial phases of tumor formation. Here, NTRK1 is linked to Miyoshi myopathy.